{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T06:24:04Z","timestamp":1762323844264},"reference-count":50,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","cidjournal.com","clinicalkey.es","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinics in Dermatology"],"published-print":{"date-parts":[[2015,9]]},"DOI":"10.1016\/j.clindermatol.2015.05.009","type":"journal-article","created":{"date-parts":[[2015,5,28]],"date-time":"2015-05-28T21:08:12Z","timestamp":1432847292000},"page":"556-562","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["Systemic involvement in localized scleroderma\/morphea"],"prefix":"10.1016","volume":"33","author":[{"given":"Anna","family":"Gorkiewicz-Petkow","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Agnieszka","family":"Kalinska-Bienias","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.clindermatol.2015.05.009_bb0005","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1097\/01.bor.0000245727.40630.c3","article-title":"Localized scleroderma","volume":"18","author":"Laxer","year":"2006","journal-title":"Curr Opin Rheumatol"},{"key":"10.1016\/j.clindermatol.2015.05.009_bb0010","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1093\/rheumatology\/kei251","article-title":"Juvenile localized scleroderma: clinical and epidemiological features in 750 children. An international study","volume":"45","author":"Zulian","year":"2006","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.clindermatol.2015.05.009_bb0015","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.jaad.2010.05.046","article-title":"Update on morphea: Part II. Outcome measures and treatment","volume":"64","author":"Fett","year":"2011","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2015.05.009_bb0020","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1001\/archdermatol.2009.79","article-title":"Distinct autoimmune syndromes in morphea: a review of 245 adult and pediatric cases","volume":"145","author":"Leitenberger","year":"2009","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.clindermatol.2015.05.009_bb0025","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1016\/j.jaad.2012.01.011","article-title":"Morphea in adults and children cohort II: patients with morphea experience delay in diagnosis and large variation in treatment","volume":"67","author":"Johnson","year":"2012","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2015.05.009_bb0030","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1111\/bjd.12606","article-title":"Short- and long-term outcome of linear morphoea in children","volume":"169","author":"Piram","year":"2013","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.clindermatol.2015.05.009_bb0035","first-page":"140","article-title":"On striae et maculae atrophicae cutis or false cicatrices of the skin","volume":"68","author":"Wilson","year":"1867","journal-title":"J Cut Med"},{"key":"10.1016\/j.clindermatol.2015.05.009_bb0040","first-page":"255","article-title":"On keloid, scleriasis, morphoea","volume":"3","author":"Fagge","year":"1868","journal-title":"Guys Hosp Rep"},{"key":"10.1016\/j.clindermatol.2015.05.009_bb0045","first-page":"315","article-title":"Diseases of the skin","volume":"31","author":"Crocker","year":"1880","journal-title":"Trans Pathol Soc London"},{"key":"10.1016\/j.clindermatol.2015.05.009_bb0050","first-page":"322","article-title":"A case of scleroderma adultorum illustrating the circumscribed and diffuse forms of the malady","volume":"31","author":"Duckworth","year":"1880","journal-title":"Trans Pathol Soc London"},{"key":"10.1016\/j.clindermatol.2015.05.009_bb0055","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1097\/00000441-193007000-00013","article-title":"A clinical study of 103 cases of scleroderma","volume":"180","author":"O'Leary","year":"1930","journal-title":"Am J Med Sci"},{"key":"10.1016\/j.clindermatol.2015.05.009_bb0060","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1001\/archneurpsyc.1932.02230150045004","article-title":"Progressive facial hemiatrophy-report of 3 cases","volume":"27","author":"Archambault","year":"1932","journal-title":"Arch Neurol Psychiatry"},{"key":"10.1016\/j.clindermatol.2015.05.009_bb0065","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1001\/archderm.1948.01520200004001","article-title":"Linear scleroderma; association with abnormalities of the spine and nervous system","volume":"58","author":"Rubin","year":"1948","journal-title":"Arch Dermatol Syphilol"},{"key":"10.1016\/j.clindermatol.2015.05.009_bb0070","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1001\/archderm.1956.01550120049012","article-title":"Localized scleroderma; a clinical study of two hundred thirty-five cases","volume":"74","author":"Christianson","year":"1956","journal-title":"AMA Arch Dermatol"},{"key":"10.1016\/j.clindermatol.2015.05.009_bb0075","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1001\/archderm.1958.01560120069011","article-title":"The prognosis of localized scleroderma","volume":"78","author":"Curtis","year":"1958","journal-title":"AMA Arch Dermatol"},{"key":"10.1016\/j.clindermatol.2015.05.009_bb0080","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.clindermatol.2006.07.004","article-title":"Systemic and localized scleroderma","volume":"24","author":"Chung","year":"2006","journal-title":"Clin Dermatol"},{"key":"10.1016\/j.clindermatol.2015.05.009_bb0085","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.jaad.2010.05.045","article-title":"Update on morphea: part I. Epidemiology, clinical presentation, and pathogenesis","volume":"64","author":"Fett","year":"2011","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2015.05.009_bb0090","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.jaad.2008.03.009","article-title":"Drug-induced morphea: report of a case induced by balicatib and review of the literature","volume":"59","author":"Peroni","year":"2008","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2015.05.009_bb0095","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.jaad.2008.09.023","article-title":"\"Borrelia-associated early-onset morphea\": a particular type of scleroderma in childhood and adolescence with high titer antinuclear antibodies? Results of a cohort analysis and presentation of three cases","volume":"60","author":"Prinz","year":"2009","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2015.05.009_bb0100","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1046\/j.1365-2133.2000.03775.x","article-title":"Morphoea is neither associated with features of Borrelia burgdorferi infection, nor is this agent detectable in lesional skin by polymerase chain reaction","volume":"143","author":"Weide","year":"2000","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.clindermatol.2015.05.009_bb0105","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1016\/j.berh.2007.09.003","article-title":"Localized scleroderma and systemic sclerosis: is there a connection?","volume":"21","author":"Gupta","year":"2007","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"10.1016\/j.clindermatol.2015.05.009_bb0110","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/S0738-081X(94)90327-1","article-title":"Localized scleroderma","volume":"12","author":"Ghersetich","year":"1994","journal-title":"Clin Dermatol"},{"key":"10.1016\/j.clindermatol.2015.05.009_bb0115","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1093\/rheumatology\/kep361","article-title":"Development and initial validation of the localized scleroderma skin damage index and physician global assessment of disease damage: a proof-of-concept study","volume":"49","author":"Arkachaisri","year":"2010","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.clindermatol.2015.05.009_bb0120","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1093\/rheumatology\/kel446","article-title":"A new computerized method for the assessment of skin lesions in localized scleroderma","volume":"46","author":"Zulian","year":"2007","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.clindermatol.2015.05.009_bb0125","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.4065\/70.11.1068","article-title":"Classification of morphea (localized scleroderma)","volume":"70","author":"Peterson","year":"1995","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.clindermatol.2015.05.009_bb0130","first-page":"171","article-title":"Localized scleroderma in adults and children. Clinical and laboratory investigations on 239 cases","volume":"13","author":"Marzano","year":"2003","journal-title":"Eur J Dermatol"},{"key":"10.1016\/j.clindermatol.2015.05.009_bb0135","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1111\/bjd.12758","article-title":"Risk factors for morphoea disease severity: a retrospective review of 114 paediatric patients","volume":"170","author":"Pequet","year":"2014","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.clindermatol.2015.05.009_bb0140","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1111\/j.1525-1470.2010.01258.x","article-title":"Localized severe scleroderma: a retrospective study of 26 pediatric patients","volume":"27","author":"Beltramelli","year":"2010","journal-title":"Pediatr Dermatol"},{"key":"10.1016\/j.clindermatol.2015.05.009_bb0145","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.jaad.2008.05.005","article-title":"Pediatric morphea (localized scleroderma): review of 136 patients","volume":"59","author":"Christen-Zaech","year":"2008","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2015.05.009_bb0150","doi-asserted-by":"crossref","first-page":"2873","DOI":"10.1002\/art.21264","article-title":"Localized scleroderma in childhood is not just a skin disease","volume":"52","author":"Zulian","year":"2005","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.clindermatol.2015.05.009_bb0155","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.det.2012.12.002","article-title":"Pediatric morphea","volume":"31","author":"Browning","year":"2013","journal-title":"Dermatol Clin"},{"key":"10.1016\/j.clindermatol.2015.05.009_bb0160","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1111\/j.1365-2133.2006.07497.x","article-title":"Evaluation of methotrexate and corticosteroids for the treatment of localized scleroderma (morphoea) in children","volume":"155","author":"Weibel","year":"2006","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.clindermatol.2015.05.009_bb0165","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.jaad.2006.10.959","article-title":"En coup de sabre morphea and Parry-Romberg syndrome: a retrospective review of 54 patients","volume":"56","author":"Tollefson","year":"2007","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2015.05.009_bb0170","doi-asserted-by":"crossref","first-page":"S115","DOI":"10.1016\/j.jaad.2004.10.881","article-title":"Disabling pansclerotic morphea: clinical presentation in two adults","volume":"53","author":"Maragh","year":"2005","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2015.05.009_bb0175","doi-asserted-by":"crossref","first-page":"106","DOI":"10.3899\/jrheum.130029","article-title":"Clinical features of patients with morphea and the pansclerotic subtype: a cross-sectional study from the morphea in adults and children cohort","volume":"41","author":"Kim","year":"2014","journal-title":"J Rheumatol"},{"key":"10.1016\/j.clindermatol.2015.05.009_bb0180","series-title":"Sclerodema and Pseudoscleroderma","first-page":"277","article-title":"Localized scleroderma","author":"Jablonska","year":"1975"},{"key":"10.1016\/j.clindermatol.2015.05.009_bb0185","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1212\/01.wnl.0000334474.88923.e3","article-title":"Neurologic manifestations of localized scleroderma: a case report and literature review","volume":"71","author":"Kister","year":"2008","journal-title":"Neurology"},{"key":"10.1016\/j.clindermatol.2015.05.009_bb0190","first-page":"1997","article-title":"Progressive facial hemiatrophy: central nervous system involvement and relationship with scleroderma en coup de sabre","volume":"30","author":"Blaszczyk","year":"2003","journal-title":"J Rheumatol"},{"key":"10.1016\/j.clindermatol.2015.05.009_bb0195","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1007\/s10067-013-2458-1","article-title":"Plaque morphea with neurological involvement-an extraordinary uncommon presentation","volume":"34","author":"Rosario","year":"2015","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.clindermatol.2015.05.009_bb0200","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1001\/archdermatol.2009.202","article-title":"Psychological distress in patients with morphea and eosinophilic fasciitis","volume":"145","author":"Kroft","year":"2009","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.clindermatol.2015.05.009_bb0205","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1136\/bjo.2007.116038","article-title":"Ocular involvement in children with localised scleroderma: a multi-centre study","volume":"91","author":"Zannin","year":"2007","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.clindermatol.2015.05.009_bb0210","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1136\/bjo.63.12.845","article-title":"Ocular involvement in scleroderma","volume":"63","author":"West","year":"1979","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.clindermatol.2015.05.009_bb0215","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/S1579-2129(09)72941-6","article-title":"Lung disease secondary to morphea en coup de sabre, a form of localized scleroderma","volume":"45","author":"Perez","year":"2009","journal-title":"Arch Bronconeumol"},{"key":"10.1016\/j.clindermatol.2015.05.009_bb0220","doi-asserted-by":"crossref","first-page":"2439","DOI":"10.3899\/jrheum.080098","article-title":"Serum autoantibodies and their clinical associations in patients with childhood- and adult-onset linear scleroderma. A single-center study","volume":"35","author":"Arkachaisri","year":"2008","journal-title":"J Rheumatol"},{"key":"10.1016\/j.clindermatol.2015.05.009_bb0225","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1093\/rheumatology\/keh487","article-title":"Localized scleroderma is an autoimmune disorder","volume":"44","author":"Takehara","year":"2005","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.clindermatol.2015.05.009_bb0230","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1016\/j.jaad.2012.04.003","article-title":"Coexistence of lichen sclerosus and morphea: a retrospective analysis of 472 patients with localized scleroderma from a German tertiary referral center","volume":"67","author":"Kreuter","year":"2012","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2015.05.009_bb0235","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1002\/art.11432","article-title":"Anti-DNA topoisomerase IIalpha autoantibodies in localized scleroderma","volume":"50","author":"Hayakawa","year":"2004","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.clindermatol.2015.05.009_bb0240","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1111\/j.1365-4362.1992.tb03933.x","article-title":"Morphea with high titer of fibronectin antibodies","volume":"31","author":"Stefanato","year":"1992","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.clindermatol.2015.05.009_bb0245","first-page":"1955","article-title":"Progression of childhood linear scleroderma to fatal systemic sclerosis","volume":"21","author":"Mayorquin","year":"1994","journal-title":"J Rheumatol"},{"key":"10.1016\/j.clindermatol.2015.05.009_bb0250","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1097\/00002281-200211000-00013","article-title":"Scleroderma overlap syndromes","volume":"14","author":"Pope","year":"2002","journal-title":"Curr Opin Rheumatol"}],"container-title":["Clinics in Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0738081X15001248?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0738081X15001248?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,22]],"date-time":"2018-09-22T04:41:50Z","timestamp":1537591310000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0738081X15001248"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,9]]},"references-count":50,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2015,9]]}},"alternative-id":["S0738081X15001248"],"URL":"https:\/\/doi.org\/10.1016\/j.clindermatol.2015.05.009","relation":{},"ISSN":["0738-081X"],"issn-type":[{"value":"0738-081X","type":"print"}],"subject":[],"published":{"date-parts":[[2015,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Systemic involvement in localized scleroderma\/morphea","name":"articletitle","label":"Article Title"},{"value":"Clinics in Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clindermatol.2015.05.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}